7-Fluoro-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
95%
- Product Code: 50089
CAS:
380638-36-8
| Molecular Weight: | 204.2004 g./mol | Molecular Formula: | C₁₁H₉FN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD02333781 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and oncological disorders. Its structural framework is often incorporated into the development of potential drug candidates due to its ability to interact with specific enzymes and receptors in the body. Researchers explore its derivatives for their potential as inhibitors or modulators in therapeutic applications, focusing on diseases such as cancer, epilepsy, and neurodegenerative conditions. Additionally, it is studied for its role in enhancing the efficacy and selectivity of pharmaceutical compounds, contributing to the advancement of targeted therapies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿3,087.00 |
+
-
|
7-Fluoro-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and oncological disorders. Its structural framework is often incorporated into the development of potential drug candidates due to its ability to interact with specific enzymes and receptors in the body. Researchers explore its derivatives for their potential as inhibitors or modulators in therapeutic applications, focusing on diseases such as cancer, epilepsy, and neurodegenerative conditions. Additionally, it is studied for its role in enhancing the efficacy and selectivity of pharmaceutical compounds, contributing to the advancement of targeted therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :